Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network
First written in FY2016. 31 of 32 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2026.
87 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the consolidated fiscal year, we made capital expenditures and other investments totaling ¥97.1 billion.」
The company made ¥97.1 billion in capital expenditures and other investments to expand production capacity, improve efficiency, enhance quality, and strengthen research and development. Construction of a new building at the Kofu Plant to strengthen the production infrastructure, including CDMO production, is continuing, with a total cost of ¥58.0 billion and completion scheduled for March 2027. - 2026-05-15AdvancedEarnings
「In fields expected to achieve high growth, we plan to continue capital investment, centered on expanding production capacity.」
The Company indicated that it would continue expanding production capacity in high-growth fields in the fiscal year ending March 2027, and invested ¥85.2 billion in the acquisition of property, plant and equipment during the current fiscal year. - FY2026-H1AdvancedAnnual report
「By using the pharmaceutical product manufacturing plant acquired in this transaction as the Terumo Group's first overseas CDMO production site, we will expand production capacity, strengthen our global capabilities, and accelerate the global development of our CDMO business.」
The company moved forward with measures to use the Leverkusen Plant in Germany as its first overseas CDMO production site and strengthen production capacity and global capabilities. - FY2025AdvancedAnnual report
「The group has continued to invest in capital expenditures aimed mainly at expanding production capacity, improving efficiency and quality in its production divisions, and strengthening its research and development divisions. During the fiscal year, the company made ¥82.5 billion in capital expenditures and other investments.」
The company continued to strengthen its global production and operating infrastructure, with capital expenditures and other investments totaling ¥82.5 billion. The new building at the Kofu Plant has a total cost of ¥58.0 billion and is scheduled for completion in March 2027. Plans to expand production facilities at VasTech and Terumo BCT are also continuing. - FY2025-H1AdvancedAnnual report
「Cash used in investing activities was ¥38.8 billion, compared with ¥36.1 billion in the same period of the previous year. The main factors were ¥31.7 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥6.9 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
During the interim consolidated accounting period, the company invested ¥31.7 billion in production facilities and other assets and ¥6.9 billion in a new IT system and other assets, continuing to strengthen its global production and operating infrastructure. - FY2024AdvancedAnnual report
「During the fiscal year, the company made ¥78.4 billion in capital expenditures and other investments.」
The company made ¥78.4 billion in capital expenditures and other investments to expand production capacity, improve efficiency and quality, and strengthen research and development. - FY2024-Q3AdvancedAnnual report
「Cash used in investing activities was ¥53.1 billion, compared with ¥41.9 billion in the same period of the previous year. The main factors were ¥40.4 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥13.4 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In the cumulative FY2024-Q3 period, the company invested ¥40.4 billion in production facilities and other assets and ¥13.4 billion in a new IT system and other assets, continuing to strengthen global operations and its production and operating infrastructure. - FY2024-Q2AdvancedAnnual report
「The main factors were ¥28.2 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥9.7 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In the cumulative FY2024-Q2 period, the company invested ¥28.2 billion in production facilities and other assets and ¥9.7 billion in a new IT system and other assets, continuing to strengthen global operations and its production and operating infrastructure. - FY2024-Q1AdvancedAnnual report
「The main factors were ¥14.7 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥4.5 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In FY2024-Q1, the company invested ¥14.7 billion in production facilities and other assets and ¥4.5 billion in a new IT system and other assets, continuing to strengthen its global production and operating infrastructure. - FY2023AdvancedAnnual report
「During the fiscal year, the company made ¥75.8 billion in capital expenditures and other investments.」
Capital expenditures and other investments totaled ¥75.8 billion in FY2023. The Cardiovascular, Medical Care Solutions, and Blood and Cell Technologies companies advanced investments to expand production capacity, renew facilities and develop source plasma-related equipment. - FY2023-Q3AdvancedAnnual report
「Cash used in investing activities was ¥41.9 billion, compared with ¥59.3 billion in the same period of the previous year. The main factors were ¥38.0 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥14.7 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In the cumulative FY2023-Q3 period, the company invested ¥38.0 billion in production facilities and other assets and ¥14.7 billion in a new IT system and other assets, continuing to strengthen global operations and its production and operating infrastructure. - FY2023-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 10 November 2022, the company resolved to construct a new factory building at the Kofu Plant in Showa, Nakakoma District, Yamanashi Prefecture, in anticipation of future production increases. The total investment based on this resolution is expected to be ¥30.7 billion.」
In preparation for future production increases, the company resolved to construct a new building at the Kofu Plant and disclosed a capacity expansion plan with an expected total investment of ¥30.7 billion. - FY2023-Q1AdvancedAnnual report
「This was mainly due to a ¥19.8 billion increase in property, plant and equipment and a ¥48.8 billion increase in goodwill and intangible assets, resulting from the yen’s depreciation and investments in production facilities and a new IT system.」
The company continued to invest in production facilities and a new IT system, resulting in increases of ¥19.8 billion in property, plant and equipment and ¥48.8 billion in goodwill and intangible assets. Progress was made in strengthening global operations and the production and operating infrastructure. - FY2022AdvancedAnnual report
「The company will strengthen its three-region production network in Costa Rica, Japan and Vietnam and work to optimize global production. In addition to improving cost efficiency, it will promote production innovation by deploying globally the automation, labor-saving and digitalization expertise developed at individual plants.」
The global production network was organized as a three-region structure comprising Costa Rica, Japan and Vietnam, and the initiatives were expanded to include the global deployment of automation, labor-saving and digitalization expertise. - FY2022-Q3AdvancedAnnual report
「Total assets increased ¥50.3 billion to ¥1,401.5 billion. This was mainly due to a ¥15.7 billion increase in property, plant and equipment from investments in production facilities and other assets, and a ¥14.9 billion increase in goodwill and intangible assets due to the yen’s depreciation and investments in a new IT system and other assets.」
The company continued to invest in production facilities and a new IT system, resulting in increases of ¥15.7 billion in property, plant and equipment and ¥14.9 billion in goodwill and intangible assets. Progress was made in strengthening global operations and the operating infrastructure. - FY2022-Q2AdvancedAnnual report
「Total assets increased ¥17.8 billion to ¥1,369.0 billion. This was mainly due to a ¥7.9 billion increase in property, plant and equipment from investments in production facilities and other assets, and a ¥3.0 billion increase in goodwill and intangible assets from investments in a new IT system and other assets.」
The company continued to invest in production facilities and a new IT system, resulting in increases of ¥7.9 billion in property, plant and equipment and ¥3.0 billion in goodwill and intangible assets. The foundations for global operations and cost competitiveness continued to be strengthened. - FY2022-Q1AdvancedAnnual report
「The main factors were ¥14.1 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥5.9 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In FY2022-Q1, the company invested ¥14.1 billion in production facilities and other assets and ¥5.9 billion in a new IT system and other assets, continuing to strengthen global operations and its production and operating infrastructure. - FY2021AdvancedAnnual report
「During the fiscal year, the company made ¥77.2 billion in capital expenditures and other investments (based on the amount of property, plant and equipment and intangible assets received; excluding consumption tax and other taxes).」
The company made ¥77.2 billion in capital expenditures and other investments during the full fiscal year to expand production capacity, improve efficiency and quality, and strengthen research and development. - FY2021-Q3AdvancedAnnual report
「Cash used in investing activities was ¥63.0 billion, compared with ¥57.1 billion in the same period of the previous year. The main factors were ¥47.4 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥15.1 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In the cumulative first 9 months of the fiscal year, the company invested ¥47.4 billion in production facilities and other assets and ¥15.1 billion in a new IT system and other assets, continuing to strengthen its global production and operating infrastructure. - FY2021-Q2AdvancedAnnual report
「Cash used in investing activities was ¥44.4 billion, compared with ¥39.7 billion in the same period of the previous year. The main factors were ¥32.9 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥11.7 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In the cumulative FY2021-Q2 period, the company invested ¥32.9 billion in production facilities and other assets and ¥11.7 billion in a new IT system and other assets. Investment to strengthen its production and operating infrastructure and global operations continued. - FY2021-Q1AdvancedAnnual report
「The main factors were ¥16.1 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥6.2 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」
In FY2021-Q1, the company invested ¥16.1 billion in production facilities and other assets and ¥6.2 billion in a new IT system and other assets, continuing to strengthen global operations and its production and operating infrastructure. - FY2020AdvancedAnnual report
「During the fiscal year, the company made ¥89.5 billion in capital expenditures and other investments (based on the amount of property, plant and equipment and intangible assets received; excluding consumption tax and other taxes).」
The company increased capital expenditures and other investments to ¥89.5 billion to expand production capacity, improve efficiency and quality, and strengthen research and development. - FY2020-Q3AdvancedAnnual report
「The main factors were ¥39.7 billion in purchases of property, plant and equipment associated with the construction of a new building at Terumo Yamaguchi Corporation and capital expenditures to increase production, and ¥16.2 billion in purchases of intangible assets associated with investments in a new IT system and the acquisition of exclusive distribution rights.」
The company continued to invest in expanding production capacity, constructing a new building, a new IT system and exclusive distribution rights, and during the first 9 months invested ¥39.7 billion in property, plant and equipment and ¥16.2 billion in intangible assets. - FY2020-Q2AdvancedAnnual report
「Gross profit increased 10.9% year on year to ¥171.5 billion, reflecting higher sales of high-margin products and cost improvements, in addition to increased revenue.」
Higher sales of high-margin products and cost improvements contributed to the 10.9% year-on-year increase in gross profit, indicating progress in improving profitability in products and production. - FY2019AdvancedAnnual report
「During the fiscal year, the company made ¥60.8 billion in capital expenditures and other investments (based on the amount of property, plant and equipment and intangible assets received; excluding consumption tax and other taxes).」
The company made ¥60.8 billion in capital expenditures and other investments during the full fiscal year to expand production capacity, renew facilities and improve the functionality of its operating systems. - FY2019-Q3AdvancedAnnual report
「Total assets increased ¥50.8 billion to ¥1,129.8 billion. This was mainly due to a ¥3.24 billion increase in property, plant and equipment, goodwill and intangible assets resulting from investments in facilities to expand production capacity and in a new IT system, as well as the yen’s depreciation against the US dollar from the end of the previous fiscal year.」
The company continued to invest in facilities to expand production capacity and in a new IT system, resulting in a ¥3.24 billion increase in property, plant and equipment and other assets from the end of the previous fiscal year. - FY2019-Q2AdvancedAnnual report
「This was mainly due to a ¥3.17 billion increase from the end of the previous fiscal year in property, plant and equipment, goodwill and intangible assets, attributable to the yen’s depreciation against the US dollar and investments in facilities to expand production capacity and in a new IT system.」
The company invested in facilities to expand production capacity and in a new IT system, resulting in a ¥3.17 billion increase in property, plant and equipment, goodwill and intangible assets from the end of the previous fiscal year. This was described as concrete progress in investment to strengthen global operations. - FY2019-Q1AdvancedAnnual report
「Gross profit increased 5.2% year on year to ¥79.9 billion, reflecting cost reductions at each company.」
Cost reductions at each company contributed to the 5.2% year-on-year increase in gross profit. - FY2018AdvancedAnnual report
「To absorb this impact and achieve sustainable growth, the company will work to strengthen global operations, including its production network, promote strategic development to strengthen its ability to generate innovation, and realize the full strength of the group by promoting the use of human resources across business and regional boundaries.」
The company explicitly identified the strengthening of global operations, including its production network, as a growth initiative for the next fiscal year. - FY2017AdvancedAnnual report
「As part of the rebuilding of the global production network and the review of the operations of each division, the company undertook these measures to further deepen global management under its medium- to long-term growth strategy starting in fiscal 2017.」
The company stated that it had rebuilt its global production network and reviewed the operations of each division, giving concrete form to its previous policy of integrating its production network. - FY2017-Q3AdvancedAnnual report
「In connection with this acquisition, the company established the subsidiary in October 2016 because it needed to take over the buildings, manufacturing equipment and other business assets subject to the acquisition held by St. Jude, as well as accept the employees.」
The company established a wholly owned subsidiary in October 2016 to take over the Puerto Rico plant’s buildings, manufacturing equipment and employees. This was described as a specific expansion of its global production network. - FY2016First statedAnnual report
「The company will timely develop and introduce products tailored to the needs of each region and enhance cost competitiveness by using its global production network to manufacture products in the optimal locations.」
An operating model combining product offerings tailored to each market with production in optimal locations.